Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes

Julian W Sacre1, Kristin Lundegard2, Kamel Mohammedi3,4

  • 1Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

PubMed

Insights

In type 2 diabetes, heart failure (HF) can precede atherosclerotic cardiovascular disease (ASCVD). Risk factors for HF as the first cardiovascular event differ from those for ASCVD, highlighting distinct pathways in diabetes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes (T2D) increases cardiovascular disease (CVD) risk.
  • Heart failure (HF) can be the initial manifestation of CVD in T2D patients, even without prior atherosclerotic cardiovascular disease (ASCVD).
  • Understanding distinct risk factors for HF versus ASCVD as first CVD events in T2D is crucial for targeted prevention.

Purpose of the Study:

  • To identify risk factors differentiating initial CVD presentation as HF versus ASCVD in individuals with T2D.
  • To analyze the specific associations of various risk factors with HF-first events compared to ASCVD-first events.

Main Methods:

  • Analysis of participants from the ORIGIN and REWIND trials with T2D and no prior CVD (N=6175).
  • Follow-up for incident CVD, categorized as HF event, ASCVD event, or other cardiovascular death.
  • Utilized multi-state models to assess event-specific risk factor associations.

Main Results:

  • Heart failure was the first CVD event in 16.8% of cases.
  • Older age, higher BMI, and elevated urine albumin-to-creatinine ratio were linked to HF-first CVD.
  • Worse LDL-cholesterol and HbA1c were more strongly associated with ASCVD-first events.
  • Risk factor profiles predicted variable probabilities for HF as the first CVD event (ranging from 5.1% to 32.0%).

Conclusions:

  • CVD presenting initially as HF is a significant concern in T2D.
  • Distinct risk factors are associated with HF-first versus ASCVD-first cardiovascular events in this population.
  • These findings underscore the need for tailored risk assessment and management strategies in T2D.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
676
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869